These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12091130)

  • 1. HLA-DRB1*15 and pediatric aplastic anemia.
    Oguz FS; Yalman N; Diler AS; Oguz R; Anak S; Dorak MT
    Haematologica; 2002 Jul; 87(7):772-4. PubMed ID: 12091130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the predictors of response to immunosuppressive therapy in severe aplastic anemia patients].
    Mu XY; Chang H; Liu T; Gong YP; Niu T; Qin H; Ma HB; Meng WT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):897-900. PubMed ID: 19950609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR frequency in Turkish aplastic anemia patients and the impact of HLA-DR2 positivity in response rate in patients receiving immunosuppressive therapy.
    Ilhan O; Beksaç M; Koç H; Akan H; Keskin A; Arslan O; Gürman G; Ozcan M; Konuk N; Uysal A
    Blood; 1995 Sep; 86(5):2055. PubMed ID: 7655036
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical implications of combined measurement bone marrow T cells intracellular IFNgamma and HLA-DRB1*1501 measurement in predicting the response to immunosuppressive therapy for aplastic anemia].
    Chen Y; Xu CG; Guo NJ; Huang P; Xiao DJ; Ding BT; Ge LF
    Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):846-9. PubMed ID: 18218241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of HLA-DRB1*15 genotype in children with acquired aplastic anemia and its relation to effect of immunosuppressive therapy].
    Huang YL; Huang SL; Huang K; Bao R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1212-5. PubMed ID: 18088469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of DRB1 *1501 and DRB1 *1502 in the pathogenesis of aplastic anemia.
    Sugimori C; Yamazaki H; Feng X; Mochizuki K; Kondo Y; Takami A; Chuhjo T; Kimura A; Teramura M; Mizoguchi H; Omine M; Nakao S
    Exp Hematol; 2007 Jan; 35(1):13-20. PubMed ID: 17198869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary study of multivariable model in predicting response to immunosuppressive therapy in patients with aplastic anemia].
    Chen Y; Xu CG; Guo NJ; Huang P; Xiao DJ; Ding BT; Ge LF; Yu Z; Chang YL; Zhou YW
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):583-6. PubMed ID: 18246811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA association is different in children and adults with severe acquired aplastic anemia.
    Führer M; Durner J; Brünnler G; Götte H; Deppner C; Bender-Götze C; Albert E
    Pediatr Blood Cancer; 2007 Feb; 48(2):186-91. PubMed ID: 16496287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus as an alternative to cyclosporine in the maintenance phase of immunosuppressive therapy for severe aplastic anemia in children.
    Alsultan A; Goldenberg NA; Kaiser N; Graham DK; Hays T
    Pediatr Blood Cancer; 2009 May; 52(5):626-30. PubMed ID: 19148946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR4-Ala74 beta is associated with risk and poor outcome of severe aplastic anemia.
    Kapustin SI; Popova TI; Lyshchov AA; Imyanitov EN; Blinov MN; Abdulkadyrov KM
    Ann Hematol; 2001 Feb; 80(2):66-71. PubMed ID: 11261326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of aplastic anaemia and Fanconi's disease with HLA-DRB1 alleles.
    Yari F; Sobhani M; Vaziri MZ; Bagheri N; Sabaghi F; Talebian A
    Int J Immunogenet; 2008 Dec; 35(6):453-6. PubMed ID: 19046304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of HLA-DR15, a minor population of paroxysmal nocturnal haemoglobinuria-type cells, and an aplastic anaemia-associated autoantibody in children with acquired aplastic anaemia.
    Yoshida N; Yagasaki H; Takahashi Y; Yamamoto T; Liang J; Wang Y; Tanaka M; Hama A; Nishio N; Kobayashi R; Hotta N; Asami K; Kikuta A; Fukushima T; Hirano N; Kojima S
    Br J Haematol; 2008 Jul; 142(3):427-35. PubMed ID: 18537977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose cyclophosphamide in the treatment of severe aplastic anemia in children.
    Jaime-Pérez JC; González-Llano O; Gómez-Almaguer D
    Am J Hematol; 2001 Jan; 66(1):71. PubMed ID: 11426504
    [No Abstract]   [Full Text] [Related]  

  • 14. Complete response to tacrolimus in a child with severe aplastic anemia resistant to cyclosporin A.
    Macartney C; Freilich M; Odame I; Charpentier K; Dror Y
    Pediatr Blood Cancer; 2009 Apr; 52(4):525-7. PubMed ID: 19058202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of human leukocyte antigen-DRB1 alleles with disease susceptibility and severity of aplastic anemia in Korean patients.
    Song EY; Park S; Lee DS; Cho HI; Park MH
    Hum Immunol; 2008 Jun; 69(6):354-9. PubMed ID: 18571007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
    Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
    Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune-mediated pathogenesis and management of pediatric aplastic anemia].
    Huang YL; Huang SL
    Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):153-5. PubMed ID: 16624043
    [No Abstract]   [Full Text] [Related]  

  • 18. Epstein-Barr virus reactivation in a patient treated with anti-thymocyte globulin for severe aplastic anemia.
    Calistri E; Tiribelli M; Battista M; Michelutti A; Corbellino M; Viale P; Fanin R; Damiani D
    Am J Hematol; 2006 May; 81(5):355-7. PubMed ID: 16628717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of HLA DR2 in acquired aplastic anemia and its impact on response to immunosuppressive therapy.
    Usman M; Adil SN; Moatter T; Bilwani F; Arian S; Khurshid M
    J Pak Med Assoc; 2004 May; 54(5):251-4. PubMed ID: 15270183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of acquired severe aplastic anemia in pediatric patients with immunosuppression and allogeneic stem cell hematopoietic transplant].
    Barriga C F; Wietstruck P A; Becker K A; Zúñiga C P; Besa De C P; Alvarez Z M; Ocqueteau T M; Bertín C P
    Rev Med Chil; 2007 Nov; 135(11):1421-8. PubMed ID: 18259653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.